Dexcom receives FDA warning letter for two manufacturing sites
The warning letter follows inspections by the FDA at Dexcom’s manufacturing facilities in San Diego and Mesa, Ariz., and ...
Verywell Health on MSN11mon
Dexcom vs. FreeStyle Libre: What to Know About These CGMs
The key differences between Dexcom and FreeStyle Libre include sensor characteristics, frequency of readings, minimum age of ...
DexCom CGM Sensor Sales to Continue Despite FDA Warning Letter
DXCM faces an FDA warning over manufacturing issues, but operations remain unaffected. However, supply-chain risks and rising ...
Dexcom receives FDA warning letter for two U.S. manufacturing facilities
Medical device maker Dexcom said it has received a warning letter from the U.S. Food and Drug Administration following ...
Dexcom launches first over-the-counter continuous glucose monitor. Here's what it's like
I think Dexcom does a good job using plain language to explain what glucose is, what affects it and why it matters. The ...
Dexcom receives warning letter based on FDA inspections of 2 plants
The company does not expect the warning letter to materially impact its manufacturing capacity, sales or ability to seek ...
DexCom falls after warning letter from FDA related to quality concerns
DexCom said that on Tuesday it received a warning letter from the U.S. FDA following inspections at its facilities in San Diego, Calif., and Mesa, Ariz. related to concerns about manufacturing ...
DexCom receives warning letter from FDA, sees no impact to FY25 guidance
In a regulatory filing, DexCom (DXCM) disclosed that on March 4, the company received a warning letter from the U.S. FDA following inspections ...
Morningstar1mon
Dexcom Earnings: Fourth Quarter Held Few Surprises, but Improved Operations Bode Well for 2025
With the salesforce ramping up and regulatory approval of the 15-day G7 sensor expected this year, we anticipate Dexcom can return to double-digit top and bottom-line growth in 2025. We think the ...